The antigenicity of ex vivo cultivated human corneal limbal epithelial and stromal cells: Temporal changes in vitro

Cornea

Volumn 29, Issue 11, 2010, Pages 1302-1307

  Oh, Joo Youn ^a,b   Ko, Jung Hwa ^a,b   Lee, Hyun Ju ^a,b   Kim, Mee Kum ^a,b   Lee, Jin Hak ^a,b   Wee, Won Ryang ^a,b  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University Biomedical Research Institute   (South Korea)

Author keywords

corneal stromal cell; costimulatory molecule; cultivation; human leukocyte antigen; limbal epithelial cell

Indexed keywords

B7 ANTIGEN; CD40 ANTIGEN; CD86 ANTIGEN; GAMMA INTERFERON; HLA ANTIGEN; HLA DR ANTIGEN; HLA G ANTIGEN;

ANALYSIS; ANTIGEN EXPRESSION; ANTIGENICITY; ARTICLE; CELL CULTURE; CLINICAL EVALUATION; CONTROLLED STUDY; CORNEA CELL; CORNEA EPITHELIUM; CORNEA STROMA; EX VIVO STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOGENICITY; IN VITRO STUDY; PRIORITY JOURNAL;

ANTIGENS, CD; CELLS, CULTURED; CORNEAL STROMA; FLOW CYTOMETRY; HLA ANTIGENS; HLA-DR ANTIGENS; HUMANS; INTERFERON-GAMMA; LIMBUS CORNEAE; TIME FACTORS;

EID: 78149279706     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/ICO.0b013e3181e3f01e     Document Type: Article

References (29)

1. Espana EM, Di Pascuale M, Grueterich M, et al. Keratolimbal allograft in corneal reconstruction. Eye. 2005;18:1182-1890.
2. Ilari L, Daya SM. Long-term outcomes of keratolimbal allograft for the treatment of severe ocular surface disorders. Ophthalmology. 2002;109: 1278-1284.
3. Solomon A, Ellies P, Anderson DF, et al. Long-term outcome of keratolimbal allograft with or without penetrating keratoplasty for total limbal stem cell deficiency. Ophthalmology. 2002;109:1159-1166.
4. Cauchi PA, Ang GS, Azuara-Blanco A, et al. A systematic literature review of surgical interventions for limbal stem cell deficiency in humans. Am J Ophthalmol. 2008;146:251-259.
5. Rao SK, Rajagopal R, Sitalakshmi G, et al. Limbal allografting from related living donors for corneal surface reconstruction. Ophthalmology. 1999;106:822-828.
6. Tseng SC, Prabhasawat P, Barton K, et al. Amniotic membrane transplantation with or without limbal allografts for corneal surface reconstruction in patients with limbal stem cell deficiency. Arch Ophthalmol. 1998;116:431-441.
7. Shi W, Gao H, Wang T, et al. Combined penetrating keratoplasty and keratolimbal allograft transplantation in comparison with corneoscleral transplantation in the treatment of severe eye burns. Clin Exp Ophthalmol. 2008;36:501-507.
8. Reinhard T, Spelsberg H, Henke L, et al. Long-term results of allogeneic penetrating limbo-keratoplasty in total limbal stem cell deficiency. Ophthalmology. 2004;111:775-782.
9. Tsubota K, Satake Y, Kaido M, et al. Treatment of severe ocular-surface disorders with corneal epithelial stem-cell transplantation. N Engl J Med. 1999;340:1697-1703.
10. Shortt AJ, Secker GA, Notara MD, et al. Transplantation of ex vivo cultured limbal epithelial stem cells: a review of techniques and clinical results. Surv Ophthalmol. 2007;52:483-502.
11. Shimazaki J, Higa K, Morito F, et al. Factors influencing outcomes in cultivated limbal epithelial transplantation for chronic cicatricial ocular surface disorders. Am J Ophthalmol. 2007;143:945-953.
12. Shortt AJ, Secker GA, Rajan MS, et al. Ex vivo expansion and transplantation of limbal epithelial stem cells. Ophthalmology. 2008;115: 1989-1997.
13. Koizumi N, Inatomi T, Suzuki T, et al. Cultivated corneal epithelial stem cell transplantation in ocular surface disorders. Ophthalmology. 2001;108: 1569-1574.
14. Ang LPK, Sotozono C, Koizumi N, et al. A comparison between cultivated and conventional limbal stem cells transplantation for Stevens-Johnson syndrome. Am J Ophthalmol. 2007;143:178-180.
15. Pellegrini G, Traverso CE, Franzi AT, et al. Long-term restoration of damaged corneal surfaces with autologous cultivated corneal epithelium. Lancet. 1997;349:990-993.
16. Osawa H, Streilein JW. MHC class I and II antigens as targets of rejection in penetrating keratoplasty in low-and high-risk mouse eyes. Cornea. 2005;24:312-318.
17. Brandt CR, Knupfer PB, Baush GA, et al. In vivo induction of Ia expression in murine cornea after intravitreal injection of interferon-g. Invest Ophthalmol Vis Sci. 1990;31:2248-2253.
18. Watson SL. Ramsay A, Dart JK, et al. Comparison of deep lamellar keratoplasty and penetrating keratoplasty in patients with keratoconus. Am J Ophthalmol. 2004;111:1676-1682.
19. Al-Torbak AA, Al-Motowa S, Al-Assiri A, et al. Deep anterior lamellar keratoplasty for keratoconus. Cornea. 2006;25:408-412.
20. Watson SL, Tuft SJ, Dart JKG. Patterns of rejection after deep lamellar keratoplasty. Ophthalmology. 2006;113:556-560.
21. Noble BA, Agrawal A, Saldana M, et al. Deep anterior lamellar keratoplasty (DALK). Cornea. 2007;26:59-64.
22. Le Discorde M, Moreau P, Sabatier P, et al. Expression of HLA-G in human cornea, an immune-privileged tissue. Hum Immunol. 2003;64: 1039-1044.
23. Higa K, Shimmura S, Shimazaki J, et al. Ocular surface epithelial cells up-regulate HLA-G when expanded in vitro on amniotic membrane substrate. Cornea. 2006;25:715-721
24. Favier B, LeMaoult J, Carosella ED. Functions of HLA-G in the immune system. Tissue Antigens. 2007;69:150-152.
25. Favier B, LeMaoult J, Rouas-Freiss N, et al. Research on HLA-G: an update. Tissue Antigens. 2007;69:207-211.
26. Selmani Z, Naji A, Zidi I, et al. Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells. Stem Cells. 2008;26:212-222.
27. Contini P, Ghio M, Poggi A, et al. Soluble HLA-A,-B,-C and-G molecules induce apoptosis in T and NK CD8+ cells and inhibit cytotoxic T cell activity through CD8 ligation. Eur J Immunol. 2003;33: 125-134.
28. Gillette TE, Chandler JW, Greiner JV. Langerhans cells of the ocular surface. Ophthalmology. 1982;89:700-711.
29. Whitsett CF, Stulting RD. The distribution of HLA antigens on human corneal tissue. Invest Ophthalmol Vis Sci. 1984;25:519-524.